...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >LIQUISOLID TECHNIQUE AS A PROMISING TOOL TO ENHANCE SOLUBILITY AND DISSOLUTION OF POORLY WATER SOLUBLE DRUG VALSARTAN
【24h】

LIQUISOLID TECHNIQUE AS A PROMISING TOOL TO ENHANCE SOLUBILITY AND DISSOLUTION OF POORLY WATER SOLUBLE DRUG VALSARTAN

机译:固体溶液技术可提高水溶性缬沙坦的溶解性和溶解性

获取原文
           

摘要

“Liquisolid Technique” considered as new technique to enhance solubility and dissolution rate of poorly water soluble drugs. These formulations are prepared by mixing drug in liquid state (solution, suspension or emulsion using non-volatile solvent) with carrier and coating material to form dry, free-flowing, readily compressible powder. In the current research work liquisolid technique is employed to enhance solubility and dissolution of antihypertensive drug Valsartan, which is poorly water soluble (0.021mg/ml) possessing very low bioavailability of 23%. Liquisolid formulation VLS9, containing Tween 80 (non-volatile solvent), Avicel PH102 (carrier) and Aerosil 200 (coating material) showed better flow properties and high in-vitro dissolution profile.
机译:“液固技术”被认为是提高水溶性差的药物的溶解度和溶解速度的新技术。这些制剂是通过将液态药物(溶液,悬浮液或使用非挥发性溶剂的乳剂)与载体和包衣材料混合以形成干燥,自由流动,易于压缩的粉末来制备的。在当前的研究工作中,采用液固技术来增强抗高血压药缬沙坦的溶解度和溶解度,该药物水溶性差(0.021mg / ml),生物利用度非常低,仅为23%。包含Tween 80(非挥发性溶剂),Avicel PH102(载体)和Aerosil 200(涂料)的液体固体制剂VLS9显示出更好的流动性和高体外溶出度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号